Instrument Inactif

Communiqués Starflick.com OTC Bulletin Board

Actions

US85529D2036

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

2023	Lotus Bio-Technology Development Corp. (OTCPK:LBTD) a acquis Pioneer Digital Health, Inc.	CI
2022	BioGnomics Lab, LLC a acquis Boomerangkit.com, LLC de Lotus Bio-Technology Development Corp. (OTCPK:LBTD).	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	16/02/23	AQ
Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	25/10/22	PR
Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	30/08/22	PR
Lotus Bio Technology Development : Current Report	19/08/22	PU
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	16/08/22	PR
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Director and Surrendering of 150,000,000 Common Shares to Treasury.	16/08/22	PR
Lotus Bio-Technology Development Corp. Announces YTD Revenues And Projections by The Newly Acquired Companies in The Digital Health And Wellness Home Testing Industry.	02/08/22	AQ
Lotus Bio-Technology Development Corp. Enters Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Focal Point, Inc. and Boomerangkit.com, LLC.	06/07/22	AQ
Lotus Bio Technology Development : Attorney Letter with Respect to Current Information	30/06/22	PU
Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent	13/04/22	AQ
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	07/04/21	AQ
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	23/02/21	AQ
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	27/01/21	AQ
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.	21/01/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez la Performance de vos Investissements grâce à notre Équipe d'Experts à vos Côtés

Sécuriser mes Investissements

fermer